Randy Brenner
Consigliere Generale presso PARATEK PHARMACEUTICALS, INC.
Profilo
Randy Brenner is currently the Chief Development & Regulatory Officer at Paratek Pharmaceuticals, Inc. He previously worked at Pfizer Inc. as the Vice President-Established Products Business Units from 2010 to 2011.
He also worked at Shire Plc as the Head-Regulatory Affairs.
Mr. Brenner completed his undergraduate degree at Muhlenberg College and his graduate degree at Temple University School of Pharmacy.
Posizioni attive di Randy Brenner
| Società | Posizione | Inizio |
|---|---|---|
| PARATEK PHARMACEUTICALS, INC. | Consigliere Generale | 03/06/2015 |
Precedenti posizioni note di Randy Brenner
| Società | Posizione | Fine |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01/09/2011 |
| SHIRE | Corporate Officer/Principal | - |
Formazione di Randy Brenner
| Muhlenberg College | Undergraduate Degree |
| Temple University School of Pharmacy | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PARATEK PHARMACEUTICALS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- Randy Brenner
